Literature DB >> 12958671

Polytetrafluoroethylene femorotibial bypass grafting: 5-year patency and limb salvage.

P Klinkert1, P J E van Dijk, P J Breslau.   

Abstract

For a femorotibial bypass graft the material of choice is autologous vein. The question remains whether prosthetic material is a reasonable alternative for limb salvage, if autologous vein is not available. From 1991 to 1998, 83 consecutive femorotibial bypass procedures were performed in 70 patients. Thin-walled, ringed 6-mm polytetrafluoroethylene (PTFE) was used, as autologous vein was not available. The indication for the femorotibial bypass was critical ischemia due to atherosclerotic occlusive disease in all cases. Three patients died in the hospital or within 30 days of the operation, resulting in a perioperative mortality rate of 3.6%. After 5 years, 33 patients had died (40%) and 3 patients were lost to follow-up (3.6%). Primary patency was 64.2% after 6 weeks and 18% +/- 5% after 5 years. Secondary patency was 74.1% after 6 weeks and 22.3% +/- 6% after 5 years. When we compared primary and secondary patency for distal anastomosis, there was no difference between the three crural arteries. The limb salvage rate was 61.9% +/- 7% after 5 years. From these results we conclude that, with a limb salvage of 61.9%, PTFE is an acceptable alternative for a femorotibial bypass graft in patients with critical ischemia, if autologous vein is not available.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12958671     DOI: 10.1007/s10016-003-0036-8

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  7 in total

1.  Development of an in vivo tissue-engineered vascular graft with designed wall thickness (biotube type C) based on a novel caged mold.

Authors:  Maya Furukoshi; Takeshi Moriwaki; Yasuhide Nakayama
Journal:  J Artif Organs       Date:  2015-08-12       Impact factor: 1.731

Review 2.  Current Status of Arterial Revascularization for the Treatment of Critical Limb Ischemia in Infrainguinal Atherosclerotic Disease.

Authors:  Ahmet Yuksel; Yusuf Velioglu; Mustafa Cagdas Cayir; Gencehan Kumtepe; Orcun Gurbuz
Journal:  Int J Angiol       Date:  2018-01-22

3.  Long-term outcome of infrapopliteal catheter-based intervention for critical limb ischemia.

Authors:  Nick N Abedi; Daniel L Davenport; Nikolaos Karagiorgos; David J Minion; Ehab E Sorial; Eric D Endean; Eleftherios S Xenos
Journal:  Int J Angiol       Date:  2009

4.  Endovascular treatment of femoropopliteal stenoses/occlusions with a SilverHawk directional atherectomy device: immediate results and 12-month follow-up.

Authors:  R Regine; O Catalano; M De Siero; G Di Costanzo; A Ragozzino
Journal:  Radiol Med       Date:  2010-07-31       Impact factor: 3.469

Review 5.  Basic data related to surgical infrainguinal revascularization procedures: a twenty year update.

Authors:  Kenneth R Ziegler; Akihito Muto; Sammy D D Eghbalieh; Alan Dardik
Journal:  Ann Vasc Surg       Date:  2011-04       Impact factor: 1.466

6.  Shifting paradigms in the treatment of lower extremity vascular disease: a report of 1000 percutaneous interventions.

Authors:  Brian G DeRubertis; Peter L Faries; James F McKinsey; Rabih A Chaer; Matthew Pierce; John Karwowski; Alan Weinberg; Roman Nowygrod; Nicholas J Morrissey; Harry L Bush; K Craig Kent
Journal:  Ann Surg       Date:  2007-09       Impact factor: 12.969

7.  Dehydration improves biomechanical strength of bioartificial vascular graft material and allows its long-term storage.

Authors:  Thomas Aper; Mathias Wilhelmi; Ulrike Boer; Skadi Lau; Nils Benecke; Andres Hilfiker; Axel Haverich
Journal:  Innov Surg Sci       Date:  2018-07-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.